Muscle Energy Technique vs. Modified Active Release Technique for Scapulocostal Syndrome: Impact on Pain, Chest Expansion, and Functional Disability
This study aims to compare the effectiveness of two treatment techniques, Muscle Energy Technique and Modified Active Release Technique, on reducing pain, improving chest expansion, and decreasing functional disability in individuals with Scapulocostal Syndrome.
Muscle Energy Technique
+ Conventional Physical Therapy
+ Modified Active Release Technique
Neurologic Manifestations+2
+ Pain
+ Signs and Symptoms
Treatment Study
Summary
Study start date: January 10, 2025
Actual date on which the first participant was enrolled.This study focuses on comparing the effects of two techniques, Muscle Energy Technique and Modified Active Release Technique, in helping patients with Scapulocostal Syndrome, a condition that affects the shoulder and chest area. The main goal is to see how these techniques impact pain, chest expansion, and functional disability in these patients. This research is crucial as it could help improve treatment options for individuals dealing with this condition. During the study, participants undergo measurements using a simple measuring tape to assess chest expansion at different points of breathing. The study also uses the Neck Disability Index, a questionnaire about daily activities, to evaluate how the condition affects the patient's daily life. Additionally, the Numeric Pain Rating Scale is used to measure the severity of pain, with scores ranging from 0 (no pain) to 10 (severe pain). These tools help the researchers determine the effectiveness of the two techniques in managing pain and improving functionality.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.46 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location